PATENT CLAIM ANALYSIS

Application Number: 16040691
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "486000"]

Abstract:
A thermoformed, tamper-resistant pharmaceutical dosage form comprises: a) a pharmacologically active ingredient; b) a polyalkylene oxide having a weight average molecular weight of more than 200,000 g/mol; and c) a zinc component, wherein the content of said zinc component is at least 1 ppm, relative to the total weight of the pharmaceutical dosage form.   When the pharmacologically active ingredient is effective against pain, the pharmaceutical dosage form may be used in a method of treating pain. When the pharmacologically active ingredient has abuse potential, the pharmaceutical dosage form may be used in a method of reducing the incidence of the abuse of said pharmacologically active ingredient.

Claim (Index 16):
A method of treating pain in a patient in need thereof, said method comprising administering to said patient a pharmaceutical dosage form according to  claim 1 , said pharmaceutical dosage form comprising a pharmacologically active ingredient effective to treat pain.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 95.0
- Lexical Diversity: 2.0339
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13891306', '15901063', '15169778', '14841829', '14979888']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7020920185079312
- 35 USC 102 Novelty (BERT): 0.5409799359007574
- Combined Prediction Score: 0.6859808102472138
- Mean Citation Score: 262.034094
- Max Citation Score: 394.24017
- Similarity Product: 322.3236240963435

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test